Search Results

Inhibition of RtTg neurons reverses methamphetamine-induced attention deficits.

• Authors : Qu, Xiaotian^1,2 (AUTHOR); Yang, Pingyuan³ (AUTHOR); Zhai, Rongwei⁴ (AUTHOR)

• Source: Acta Neuropathologica Communications. 11/22/2024, Vol. 12 Issue 1, p1-15. 15p.

Record details

Identification of seven psychedelic 2,5‐dimethoxy‐phenylethyl‐amine‐based designer drugs via benchtop 1H nuclear magnetic resonance spectroscopy.

• Authors : Araneda, Juan F.¹ (AUTHOR); Baumgarte, Marion² (AUTHOR); Lange, Marie² (AUTHOR)

• Source: Magnetic Resonance in Chemistry. Feb2023, Vol. 61 Issue 2, p66-72. 7p.

Record details

Comparison of LC-MS and LC-DAD Methods of Detecting Abused Piperazine Designer Drugs.

• Authors : Welz, Anna¹ (AUTHOR) ; Koba, Marcin¹ (AUTHOR) ; Kośliński, Piotr¹ (AUTHOR)

• Source: Journal of Clinical Medicine. Apr2022, Vol. 11 Issue 7, p1758-N.PAG. 20p.

Record details

In Silico Screening of Therapeutic Targets as a Tool to Optimize the Development of Drugs and Nutraceuticals in the Treatment of Diabetes mellitus : A Systematic Review.

• Authors : Gomes, Ana Francisca T.¹ (NURSE) ; de Medeiros, Wendjilla F.¹ (NURSE) ; Medeiros, Isaiane² (NURSE)

Subjects: *DRUG development; *MOLECULAR dynamics; *DRUG target

• Source: International Journal of Molecular Sciences. Sep2024, Vol. 25 Issue 17, p9213. 15p.

Record details

Characterization of Three Novel 4-Methylaminorex Derivatives Applied as Designer Drugs.

• Authors : Seibert, Elisabeth¹ (AUTHOR); Kunert, Olaf¹ (AUTHOR); Pferschy-Wenzig, Eva-Maria² (AUTHOR)

Subjects: *ULTRAVIOLET spectrometry; *DESIGNER drugs; *CHIRAL stationary phases

• Source: Molecules. 9/15/2022, Vol. 27 Issue 18, p5770-N.PAG. 8p.

Record details

Laser Lights and Designer Drugs: New Techniques for Descending Levels of Mechanisms "in a Single Bound"?

• Authors : Bickle, John^1,2 (AUTHOR)

• Source: Topics in Cognitive Science. Oct2020, Vol. 12 Issue 4, p1241-1256. 16p.

Record details

Construction of pioneering quantitative structure activity relationship screening models for abuse potential of designer drugs using index of ideality of correlation in monte carlo optimization.

• Authors : Kumar, Ashwani¹ (AUTHOR) ; Kumar, Parvin² (AUTHOR)

Subjects: *STRUCTURE-activity relationships; *MONTE Carlo method; *DESIGNER drugs

• Source: Archives of Toxicology. Sep2020, Vol. 94 Issue 9, p3069-3086. 18p. 5 Diagrams, 3 Charts, 3 Graphs.

Record details

Designer Drugs: An Emerging Challenge in Substance-Induced Disorders.

• Authors : Turner, Richard V.¹; Sprong, Matthew E.²

• Source: Journal of Rehabilitation. Apr-Jun2020, Vol. 86 Issue 2, p4-12. 9p.

Record details

Insights into the Silylation of Benzodiazepines Using N , O -Bis(trimethylsilyl)trifluoroacetamide (BSTFA): In Search of Optimal Conditions for Forensic Analysis by GC-MS.

• Authors : Vargas Mena, Eleazar¹ (AUTHOR) ; Herrera Giraldo, Eliana R.² (AUTHOR) ; Gómez Castaño, Jovanny A.² (AUTHOR)

Subjects: *GAS chromatography/Mass spectrometry (GC-MS); *PSYCHIATRIC drugs; *PRINCIPAL components analysis

• Source: Molecules. Dec2024, Vol. 29 Issue 24, p5884. 20p.

Record details

Pharmacological affinity fingerprints derived from bioactivity data for the identification of designer drugs.

• Authors : He, Kedan¹ (AUTHOR)

• Source: Journal of Cheminformatics. 6/7/2022, Vol. 14 Issue 1, p1-19. 19p.

Record details